Earnings

AbbVie Affirms FY2026 Adj EPS Guidance of $13.87-$14.07 vs $14.08 Est

Sep 3, 2026 · 09:17 AM ET· updated 1h ago

AbbVie (NYSE:ABBV) affirms FY2026 Adj EPS guidance from $13.87-$14.07 to $13.87-$14.07 vs $14.08 analyst estimate..

Why It Matters

AbbVie said its profit target for next year will probably land just a tiny bit lower than what expert guessers predicted. When a company keeps its promise but it's slightly below what people expected, it can make investors feel a little less excited.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ABBV258.87

-2.85 (-1.09%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.